Dr. Richard Bryce

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Richard Bryce

enGene Therapeutics Inc. reported in an 8-K filed July 24, 2024 that Dr. Richard Bryce resigned as Chief Medical Officer, effective July 19, 2024.

“Dr. Bryce departed the Company effective July 19, 2024, pursuant to the terms of a Transition Services Agreement and General Release.”

enGene Therapeutics Inc. Form 8-K, filed July 24, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Dr. Richard Bryce's recent executive appointments or departures and cite the source filings.”

Recorded current and former roles; source labels appear when available.

Recorded roles and call appearances connecting this person to public companies.

ENGN

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.